Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
Completed · Not applicable
Conditions studied: Quality of Life
In brief
The purpose of this study is to (1) describe patient and clinician engagement in web-based symptom self-monitoring, (2) identify differences in symptom management between intervention and usual care groups, and (3) identify potential outcomes of real-time symptom tracking and management. With the assistance of the study coordinator, participants randomized to the intervention will create an account with Noona. Patients will be instructed to log symptoms as often as relevant using their own personal devices. Patients will also be prompted once per week for 24 weeks to log any recent symptoms. These participants will be sent a Symptom Questionnaire (SQ) via the Noona tool that summarizes their symptoms and distress one week prior to each oncology clinic visit. Symptoms designated as clinically severe either during regular symptom logging or via the SQ will trigger a prompt to contact the clinical team for immediate follow-up.
Key facts
- Study ID
- NCT05112198
- Run by
- Stanford University
- People needed
- 190
- Starts
- 2018-03-01
- Expected to finish
- 2024-08-23
- Last updated by the study team
- 2026-03-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals (men and women) aged 18 years or older
- Biopsy proven (recurrent or metastatic) advanced lung or gastrointestinal cancer
- No limit on prior lines of therapy in the metastatic setting
- ECOG performance status of 0-2
- Estimated life expectancy of at least 6 months
- Access to smartphone, tablet or computer with capability to utilize symptom tracking application
- Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures
- Willing and able to comply with all study procedures
You may not qualify if…
- Concurrent disease or condition that interferes with participation or safety
- Non-english speaking, as the application is developed in the english language
- Non-castrate resistant prostate cancer
- Enrolled in other non-therapeutic or therapeutic clinical trials
Where it is running
- Stanford Cancer Institute — Palo Alto, California, United States
- UCSF Helen Diller Medical Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.